Drug use in 17-year-olds: analysis of the ESCAPAD survey
Tendances n° 100, OFDT, 8 p.
Set up in 2000 by the OFDT in partnership with the National Service Directorate (DSN), the ESCAPAD survey has been focusing on late adolescence, providing information on a crucial period for psychoactive substance use in the general population. From 17 to 21 March 2014, the eighth ESCAPAD survey was conducted, with 26,351 French adolescents questioned about their health and their use of psychoactive substances. Issue 100 of Tendances (“Trends”) presents the changing trends in the use of psychoactive substances (both legal and illegal) over the past fifteen years in mainland France, incorporating 2014 data on alcoholic beverage, tobacco and cannabis use. It then examines, from a variety of perspectives, new questions concerning the use of e-cigarettes, shisha, the evolution in regular polydrug use and offers an estimate of the proportion of cannabis users who are potentially dependent. The last section covers the social and family factors associated with regular use.
Authors : Stanislas Spilka, Olivier Le Nézet, Marcus Ngantcha, François Beck
Download the PDF file (615 Ko)
Drugs in Europe
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.